Target intelligence / Profile preview

Duck reovirus TH11 virion antigen (DRV TH11 antigen)

Target
DRV TH11 antigen
Molecular classification
Viral structural protein, Capsid protein
01

Overview

Duck reovirus (DRV) strain TH11 is a highly pathogenic avian orthoreovirus that causes significant economic losses in the poultry industry, particularly through spotted liver disease in Muscovy ducks (Zhang et al., 2019). The virion antigens, which include structural proteins like sigma C (σC), sigma B (σB), and mu B (μB), are the primary targets for neutralizing antibodies (Yun et al., 2014). The σC protein is especially important as it functions as the viral attachment protein, facilitating entry into host cells; therefore, it is a major focus for vaccine development (Wang et al., 2020). These antigens are considered indirect immune targets because therapeutic interventions, such as inactivated or subunit vaccines, are designed to elicit a host antibody response that subsequently neutralizes the virus (Chen et al., 2018). Additionally, hyperimmune yolk antibodies (IgY) are used as a passive immunotherapy to provide immediate protection by binding to these virion antigens and preventing infection in young ducklings (Wu et al., 2021). Understanding the antigenic structure of the TH11 strain is crucial for overcoming challenges related to antigenic variation and ensuring the efficacy of immunization programs. The interaction between host antibodies and these antigens is the cornerstone of both natural immunity and clinical management of the disease.

Other names
Muscovy duck reovirus TH11 antigenMDRV TH11 antigenDuck orthoreovirus TH11 structural protein
02

Mechanism of action

Neutralization of viral infectivity by blocking attachment to host receptors and promoting viral clearance via antibody-mediated mechanisms.

03

Biological functions

Viral attachmentViral entryHost cell interactionImmune response induction
04

Disease associations

InfectionMuscovy duck reovirus diseaseLiver and spleen necrosis
05

Safety considerations

Antigenic drift leading to vaccine escapePotential for incomplete inactivation in live-attenuated preparationsShort duration of passive immunity from yolk antibodies
06

Interacting drugs

Inactivated Duck Reovirus Vaccine

2 more in the full profile.

07

Biomarkers

Anti-DRV antibody titerViral RNA load

Beyond the preview

Go deeper on Duck reovirus TH11 virion antigen (DRV TH11 antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duck reovirus TH11 virion antigen (DRV TH11 antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call